BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2016
View Archived Issues
Vertex describes discovery of DNA-PK inhibitor
Read More
GlaxoSmithKline develops a second-generation HCV NS5A replication complex inhibitor
Read More
Zymeworks completes acquisition of Kairos Therapeutics
Read More
MN-166 receives FDA fast track designation for progressive multiple sclerosis
Read More
Bayer Schering Pharma discloses prostanoid FP receptor antagonists
Read More
Biolab Sanus Farmaceutica patents cyclic nucleotide inhibitors
Read More
HEC Pharm announces prostanoid DP2 receptor antagonists
Read More
Samumed divulges Wnt signaling inhibitors
Read More
RaQualia and Asahi Kasei Pharma enter new research collaboration agreement
Read More
Celyad and Institut Curie to collaborate on immuno-oncology program
Read More
Neuropore Therapies' NPT200-11 well tolerated in phase I study
Read More
Genisphere and University of Pennsylvania enter research agreement
Read More
Eiger BioPharmaceuticals completes merger with Celladon
Read More
Pfizer joins the Human Vaccines Project
Read More
Santen China and Chongqing Kerui enter a new strategic collaboration
Read More
OncoVent, a new company in China focusing on development of cancer immunotherapies
Read More
Bristol-Myers Squibb discloses novel HCV NS3 protease inhibitor
Read More
Aprecia Pharmaceuticals launches first FDA-approved 3D printed tablets
Read More
Lilly's ixekizumab approved in the U.S. for plaque psoriasis
Read More
OncoTherapy Science reports completion of phase I/II study of cancer vaccine OTSGC-A24
Read More
Alirocumab meets primary endpoint in ODYSSEY ESCAPE trial
Read More
BRD4 inhibitors demonstrate preclinical efficacy
Read More
bioLytical completes preclinical prototype assay to detect Zika, Dengue and Chikungunya antibodies
Read More
Janssen announces more collaborations through its DIA unit
Read More
Novel POLG2 variant may be associated with mitochondrial DNA depletion syndrome
Read More
AstraZeneca's ticagrelor stroke study misses primary endpoint
Read More